Application of polyethyleneglycol (PEG)-modified liposomes for oral vaccine: Effect of lipid dose on systemic and mucosal immunity

Journal of Controlled Release

Volumn 89, Issue 2, 2003, Pages 189-197

  Minato, Seiichiro ^a   Iwanaga, Kazunori ^b   Kakemi, Masawo ^b   Yamashita, Shinji ^c   Oku, Naoto ^a  

^a UNIVERSITY OF SHIZUOKA   (Japan)

^b OSAKA MEDICAL COLLEGE   (Japan)

^c SETSUNAN UNIVERSITY   (Japan)

Author keywords

Liposome; Mucosal immune response; Oral vaccine; Polyethyleneglycol (PEG)

Indexed keywords

ANTIGENS; ENCAPSULATION; PHOSPHOLIPIDS; VACCINES;

IMMUNE RESPONSE;

POLYETHYLENE GLYCOLS;

ANTIGEN; IMMUNOGLOBULIN G; LIPID; LIPOSOME; MACROGOL; OVALBUMIN; PHOSPHOLIPID; VACCINE;

ANIMAL EXPERIMENT; ARTICLE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DOSE CALCULATION; DOSE RESPONSE; DRUG MECHANISM; ENCAPSULATION; FEMALE; IMMUNE RESPONSE; IMMUNITY; IMMUNOGLOBULIN BLOOD LEVEL; IMMUNOREGULATION; INTESTINE; INTESTINE MUCOSA; MUCOSAL IMMUNITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DETERMINATION; PROTEIN SECRETION;

EID: 0242500998     PISSN: 01683659     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-3659(03)00093-2     Document Type: Article

References (28)

1. McGhee J.R., Kiyono H. New perspectives in vaccine development: mucosal immunity to infections. Infect. Agents Dis. 2:(2):1993;55-73.
2. O'Hagan D.T. Oral delivery of vaccine. Formulation and clinical pharmacokinetic considerations. Clin. Pharmacokinet. 22:(1):1992;1-10.
3. Michalek S.M., Childers N.K., Katz J., Denys F.R., Berry A.K., Eldridge J.H., McGhee J.R., Curtiss R. 3rd. Liposomes as oral adjuvants. Curr. Top. Microbiol. Immunol. 146:1989;51-58.
4. Childers N.K., Michalek S.M., Pritchard D.G., McGhee J.R. Mucosal and systemic responses to an oral liposome-Streptococcus mutants carbohydrate vaccine in humans. Reg. Immunol. 3:(6):1990;289-296.
5. Wachsmann D., Klein J.P., Scholler M., Frank R.M. Local and systemic immune response to orally administered liposome-associated soluble S. mutants cell wall antigens. Immunology. 54:(1):1985;189-193.
6. Laverman P., Brouwers A.H., Dams E.T., Oyen W.J., Storm G., van Rooijen N., Corstens F.H., Boermann O.C. Preclinical and clinical evidence for disappearance of long-circulating characteristics of polyethylene glycol liposomes at low lipid dose. J. Pharmacol. Exp. Ther. 293:(3):2000;996-1001.
7. Oku N., Tokudome Y., Asai T., Tsukada H. Evaluation of drug targeting strategies and liposomal trafficking. Curr. Pharm. Design. 6:(16):2000;1669-1691.
8. Tomizawa H., Aramaki Y., Fujii Y., Hara T., Suzuki N., Yachi K., Kikuchi H., Tsuchiya S. Uptake of phosphatidylserine liposomes by rat Peyer's patches following intraluminal administration. Pharm. Res. 10:(4):1993;549-552.
9. Aramaki Y., Tomizawa H., Hara T., Yachi K., Kikuchi H., Tsuchiya S. Stability of liposomes in vitro and their uptake by rat Peyer's patches following oral administration. Pharm. Res. 10:(8):1993;1228-1231.
10. Kakutani T., Yamaoka K., Hashida M., Sezaki H. A new method for assessment of drug disposition in muscle: application of statistical moment theory to local perfusion systems. J. Pharmacokinet. Biopharm. 13:(6):1985;609-631.
11. Iwanaga K., Ono S., Narioka K., Morimoto K., Kakemi M., Yamashita S., Nango M., Oku N. Oral delivery of insulin by using surface coated liposomes: improvement of stability of insulin in GI tract. Int. J. Pharm. 157:1997;73-80.
12. Ouadahi S., Paternostre M., Andre C., Genin I., Thao T.X., Puisieux F., Devissaguet J.Ph., Barratt G. Liposomal formulations for oral immunotherapy: in-vitro stability in synthetic intestinal media and in-vivo efficacy in the mouse. J. Drug Target. 5:1998;365-378.
13. Eldridge J.H., Staas J.K., Chen D., Marx P.A., Tice T.R., Gilley R.M. New advances in vaccine delivery systems. Semin. Hematol. 30:(4 Suppl. 4):1993;16-24.
14. Frey A., Giannasca K.T., Weltzin R., Giannasca P.J., Reggio H., Lencer W.I., Neutra M.R. Role of the glycocalyx in regulating access of microparticles to apical plasma membranes of intestinal epithelial cells: implications for microbial attachment and oral vaccine targeting. J. Exp. Med. 184:(3):1996;1045-1059.
15. Jepson M.A., Clark M.A., Foster N., Mason C.M., Bennett M.K., Simmons N.L., Hirst B.H. Targeting to intestinal M cells. J. Anat. 189:(Pt. 3):1996;507-516.
16. Brayden D.J. Oral vaccination in man using antigens in particles: current status. Eur. J. Pharm. Sci. 14:(3):2001;183-189.
17. Saez R., Goni F.M., Alonso A. The effect of bilayer order and fluidity on detergent-induced liposome fusion. FEBS Lett. 179:(2):1985;311-315.
18. Eldride J.H., Hammond C.J., Meulbroek J.A., Staas J.K., Gilley R.M., Tice T.R. Controlled vaccine release in the gut-associated lymphoid tissue. I. Orally administered biodegradable microspheres target the Peyer's patches. J. Control. Release. 11:1990;205-214.
19. Lavelle E.C., Sharif S., Thomas N.W., Holland J.J., Davis S.S. The importance of gastrointestinal uptake of particles in the design of oral delivery systems. Adv. Drug Deliv. Rev. 18:1995;5-22.
20. Francis G.E., Delgado C., Fisher D., Malik F., Agrawal A.K. Polyethylene glycol modification: relevance of improved methodology to tumor targeting. J. Drug Target. 3:(5):1996;321-340.
21. Allen T.M., Austin G.A., Chonn A., Lin L., Lee K.C. Uptake of liposomes by cultured mouse bone marrow macrophage: influence of liposome composition and size. Biochim. Biophys. Acta. 1061:(1):1991;56-64.
22. Zeisig R., Eue I., Kosch M., Fichtner I., Arndt D. Preparation and properties of sterically stabilized hexadecylphosphocholine (miltefosine)-liposomes and influence of this modification on macrophage activation. Biochim. Biophys. Acta. 1283:(2):1996;177-184.
23. Iwanaga K., Ono S., Narioka K., Kakemi M., Morimoto K., Yamashita S., Namba Y., Oku N. Application of surface-coated liposomes for oral delivery of peptide: effect of coating the liposome's surface on the GI transit of insulin. J. Pharm. Sci. 88:(2):1999;248-252.
24. Jackson S., Mestecky J., Childers N.K., Michalek S.M. Liposomes containing anti-idiotypic antibodies: an oral vaccine to induce protective secretory immune responses specific for pathogens of mucosal surfaces. Infect. Immunol. 58:(6):1990;1932-1936.
25. Smith D.J., King W.F., Barnes L.A., Trantolo D., Wise D.L., Taubman M.A. Facilitated intestinal induction of mucosal and systemic immunity to mutants streptococcal glucosyltransferase peptide vaccines. Infect. Immunol. 69:(8):2001;4767-4773.
26. Lee M.H., Roussel Y., Wilks M., Tabaqchali S. Expression of Helicobactor pylori urease subunit B gene in Lactococcus lactis MG1363 and its use as a vaccine delivery system against H. pylori infection in mice. Vaccine. 19:(28-29):2001;3927-3935.
27. Lidbury B.A., Grissell T.V., Sizer P.J., Clancy R., Cripps A.W. Studies on the IgA-independent immunological responses in mice to influenza virus challenge after oral vaccination with irradiated whole virus and an erythrocyte complex. Immunol. Cell Biol. 78:(2):2000;149-155.
28. Marx P.A., Compans R.W., Gettie A., Staas J.K., Gilley R.M., Mulligan M.J., Yamshchikov G.V., Chen D., Eldrige J.H. Protection against vaginal SIV transmission with microencapsulated vaccine. Science. 260:(5112):1993;1323-1327.